The crude drug "Siberian Ginseng (SG)" has long been used in empirical Orie
ntal medicine for the nonspecific enhancement of resistance in humans and a
nimals. In this study, we investigated the effect of cell cultured SG by or
al administration in mast cell-mediated allergic reactions. SG dose-depende
ntly inhibited compound 48/80-induced systemic allergy with doses of 10(-2)
to 1 g/kg 1 h before oral administration. Of special note, SG inhibited sy
stemic allergy with the dose of I g/kg by 25%. SG (1 g/kg) also inhibited p
assive cutaneous allergic reaction by 51%. SG dose-dependently inhibited hi
stamine release from rat peritoneal mast cells. When SG (0.01 mg/ml) was ad
ded, the secretion of tumor necrosis factor-alpha (TNF-alpha) and interleuk
in-6 in antidinitrophenyl (DNP) IgE antibody-stimulated mast cells was inhi
bited 39.5% and 23.3%, respectively. In addition, SG inhibited anti-DNP IgE
antibody-stimulated TNF-alpha protein expression in mast cells. Our studie
s provide evidence that SG may be beneficial in the treatment of various ty
pes of allergic diseases.